CIK 0001124105 · Accelerated filer<br>Smaller reporting company
GYRE THERAPEUTICS, INC.
Sign in to watch- Ticker
- GYRE
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 562020050
- Phone
- (858) 284-0115
- Business address
- 12730 HIGH BLUFF DRIVE, SUITE 250, SAN DIEGO, CA, 92130
- Former names
- CATALYST BIOSCIENCES, INC., TARGACEPT INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-08-03 | Weston Claire Director | Grant or award · Stock Option (Right to Buy) | +40,000 | 40,000 | ||
| 2026-08-03 | Kirkby Maxwell Director | Grant or award · Stock Option (Right to Buy) | +40,000 | 40,000 | ||
| 2026-06-18 | Ye Weiguo Chief Operating Officer | Option exercise | +3,000 | $0.75 | $2K | 703,000 |
| 2026-06-18 | Ye Weiguo Chief Operating Officer | Sale | −3,000 | $6.35 | $19K | 700,000 |
| 2026-06-18 | Ye Weiguo Chief Operating Officer | Option exercise · Stock Option (Right to Buy) | −3,000 | 827,701 | ||
| 2026-06-11 | Ye Weiguo Chief Operating Officer | Option exercise | +2,800 | $0.75 | $2K | 702,800 |
| 2026-06-11 | Ye Weiguo Chief Operating Officer | Sale | −2,800 | $6.17 | $17K | 700,000 |
| 2026-06-11 | Ye Weiguo Chief Operating Officer | Option exercise · Stock Option (Right to Buy) | −2,800 | 838,701 | ||
| 2026-06-10 | Carmichael Gordon Director | Grant or award · Stock Option (Right to Buy) | +40,000 | 40,000 | ||
| 2026-06-10 | Epstein David M. Director | Grant or award · Stock Option (Right to Buy) | +40,000 | 40,000 | ||
| 2026-06-10 | Weng Dan Director | Grant or award · Stock Option (Right to Buy) | +40,000 | 40,000 | ||
| 2026-06-10 | Parry Renate Director | Grant or award · Stock Option (Right to Buy) | +40,000 | 40,000 | ||
| 2026-06-10 | Zhang Ping Director | Grant or award · Stock Option (Right to Buy) | +40,000 | 40,000 | ||
| 2026-06-10 | Nussbaum Rodney L Director | Grant or award · Stock Option (Right to Buy) | +40,000 | 40,000 | ||
| 2026-06-10 | Ye Weiguo Chief Operating Officer | Option exercise | +5,000 | $0.75 | $4K | 705,000 |
| 2026-06-10 | Ye Weiguo Chief Operating Officer | Sale | −5,000 | $6.24 | $31K | 700,000 |
| 2026-06-10 | Ye Weiguo Chief Operating Officer | Option exercise · Stock Option (Right to Buy) | −5,000 | 830,701 | ||
| 2026-06-10 | Ye Weiguo Chief Operating Officer | Option exercise | +6,418 | $0.75 | $5K | 706,418 |
| 2026-06-10 | Ye Weiguo Chief Operating Officer | Sale | −6,418 | $6.21 | $40K | 700,000 |
| 2026-06-10 | Ye Weiguo Chief Operating Officer | Option exercise · Stock Option (Right to Buy) | −6,418 | 841,501 |
Page 1 of 11 · 215 trades